The first case of meningitis associated with SARS-CoV-2 BA.2 variant infection with persistent viremia.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 05 08 2022
revised: 30 08 2022
accepted: 08 09 2022
pubmed: 16 9 2022
medline: 2 11 2022
entrez: 15 9 2022
Statut: ppublish

Résumé

Severe neurological disorders and vascular events during COVID-19 have been described. Here, we describe the first case of a female patient infected with the SARS-CoV-2 BA.2 Omicron variant of concern with meningitis with newly diagnosed central demyelinating disease.

Identifiants

pubmed: 36108959
pii: S1201-9712(22)00510-0
doi: 10.1016/j.ijid.2022.09.011
pmc: PMC9468051
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-40

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests to declare.

Auteurs

Alessandra D'Abramo (A)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Serena Vita (S)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy. Electronic address: serena.vita@inmi.it.

Francesca Colavita (F)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Eleonora Cimini (E)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Shalom Haggiag (S)

Department of Neurology, San Camillo-Forlanini, Rome, Italy.

Gaetano Maffongelli (G)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Maria Beatrice Valli (MB)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Nazario Bevilacqua (N)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Angela Corpolongo (A)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Maria Letizia Giancola (ML)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Fabrizio Maggi (F)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Chiara Agrati (C)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Emanuele Nicastri (E)

National Institute of Infectious Diseases Lazzaro Spallanzani, Institute of Hospitalization and Scientific Care, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH